SOTALOL Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is sustituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. (Chemical Entities of Biological Interest Ontology, CHEBI_63622)
External Link https://dgidb.org/results?searchType=drug&searchTerms=SOTALOL
Similar Terms
Downloads & Tools

Genes

16 interacting proteins for the SOTALOL drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
RMP24 ribonuclease MRP subunit p24 1.65412
NOS1AP nitric oxide synthase 1 (neuronal) adaptor protein 0.508961
KCNE1 potassium channel, voltage gated subfamily E regulatory beta subunit 1 0.413531
KCNE2 potassium channel, voltage gated subfamily E regulatory beta subunit 2 0.254481
GRK4 G protein-coupled receptor kinase 4 0.236304
ADRB1 adrenoceptor beta 1 0.123442
GRK5 G protein-coupled receptor kinase 5 0.122528
ADRB2 adrenoceptor beta 2, surface 0.0751875
ADRA2C adrenoceptor alpha 2C 0.0268963
KCNH2 potassium channel, voltage gated eag related subfamily H, member 2 0.0180286
CYP2C9 cytochrome P450, family 2, subfamily C, polypeptide 9 0.0151755
CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19 0.0138711
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2 0.0113296
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 0.010829
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.00746783
AR androgen receptor 0.00372971